RELATED CONTENT
News | Prostate Cancer
July 1, 2022 — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care ...
July 01, 2022 
News | Focused Ultrasound Therapy
March 17, 2021 — On the heels of the country’s deadliest year for drug overdoses, the West Virginia University ...
March 17, 2021 
News | Focused Ultrasound Therapy
March 2, 2021 — West Virginia University scientists used magnetic resonance imaging (MRI) scans to show what happens ...
March 02, 2021 
News | Focused Ultrasound Therapy
February 16, 2021 — Insightec, a global healthcare company focused on creating the next generation of patient care ...
February 16, 2021 
News | Focused Ultrasound Therapy
December 18, 2020 — Philips and InSightec, a global healthcare company focused on the therapeutic power of acoustic ...
December 18, 2020 
News | Focused Ultrasound Therapy
October 30, 2020 — A team of researchers in Madrid, Spain, and another team in Toronto, Canada, are the first in the ...
October 30, 2020 
News | Focused Ultrasound Therapy
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s Exablate Neuro compatible with the Signa Premier magnetic resonance imaging (MRI) system from GE Healthcare. The Exablate Neuro is a focused ultrasound platform for treating deep in the brain with no surgical incisions. MR imaging provides a comprehensive anatomical survey of the treatment area, patient-specific planning and real-time thermal monitoring throughout the treatment.
July 10, 2019 
News | Focused Ultrasound Therapy
May 9, 2019 — A new clinical trial at The Ohio State University Wexner Medical Center and two other sites is testing an ...
May 09, 2019 
Technology | Focused Ultrasound Therapy
Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of Exablate Neuro to include the treatment of patients with tremor-dominant Parkinson's disease (PD).
December 21, 2018 
News | Focused Ultrasound Therapy
October 1, 2018 — The U.S. Food and Drug Administration (FDA) approved the compatibility of Insightec’s Exablate Neuro ...
October 01, 2018 